5 prospective ETFs on S&P 500

Despite concerns about inflation, S&P 500 reaches new highs. Recent data on the income of technology companies and retail increased the optimistic mood. Profit 467 participants S&P 500 for the III quarter increased by 42,1% compared to the same period last year. We publish a selection 5 the most promising ETF to S&P500 by Zacks Investment Research.

5 prospective ETFs on S&P 500

iShares S&P 500 Growth ETF (ticker IVW) tracks the growth index S&P 500 and contains 242 stock. The fund is largely focused on the two largest companies, each of which has a double-digit rating. Besides, iShares S index&P 500 Growth ETF shifted towards IT companies on 42,8%, while retail, communication and healthcare round out the next three positions with double-digit indicators in each.

+7,9% for the last month.

Annual Management Fee: 0.18%.

Assets: $39,8.

SPDR S&P 500 Growth ETF (ticker ticker spyg) also tracks the growth index S&P 500, having in your cart 242 stock.

+7,9% for the last month.

Annual Management Fee: 0.04%.

Assets: $15,4 billion.

iShares Core S&P US Growth ETF (ticker IUSG) tracks the growth index S&P 900, which measures the growth rates of large and medium-sized sectors of the US stock market capitalization. IUSG contains 472 stock, mainly the two largest companies. Information technology dominates the portfolio: 41,6% assets.

+7,9% for the last month.

Annual Management Fee – 0.04%.

Assets: $13,6 billion.

Vanguard S&P 500 Growth ETF (ticker ticker voog), similar to SPYG and IVW, tracks the growth index S&P 500, has a cart from 242 valuable papers.

+8,0% per month.

Annual Management Fee – 0.10%.

Assets: $7,5 billion.

Invesco S&P 500 Pure Growth ETF (ticker RPG) slightly different from other funds and offers access to companies, which show strong growth characteristics in the S index&P500. RPG tracks S net growth index&P500 and contains only 75 shares in your basket, none of them are more than 3,1% assets. And here information technology dominates the portfolio – 41,4% assets.

  Onco-biotech company Tyra Biosciences filed for IPO

+11,6% for the last month.

Annual Management Fee – 0.35%.

Assets: $3,7 billion.

Scroll to Top